| Financial Year |
March 31 2023 |
| Monetary Funds |
6,247,296.83 |
| Held-for-trading Financial Assets |
1,019.16 |
| Notes Receivable |
-- |
| Accounts Receivable |
41,161,511.06 |
| Advances to Suppliers |
102,339,150.88 |
| Other Receivables |
38,393,948.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,342,433.39 |
| Other Current Assets |
19,073,425.27 |
| Total Current Assets |
208,558,785.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
37,271,928.52 |
| Investment Properties |
27,514,771.06 |
| Fixed Assetes |
170,081.76 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
1,186,414.10 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
66,244,368.21 |
| Total Assets |
274,803,153.51 |
| Short-Term Loans |
65,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
35,648,622.90 |
| Accounts Received In Advance |
40,559,319.82 |
| Employee Compensation Payable |
15,475,293.24 |
| Taxes Payable |
21,467,672.90 |
| Interest Payable |
14,366,797.33 |
| Dividend Payable |
5,518,224.20 |
| Other payables |
202,761,116.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
141,000,000.00 |
| Other Current Liabilities |
715,046.69 |
| Sub-Total of Current Liabilities |
528,178,561.33 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
-- |
| Total Liabilities |
528,178,561.33 |
| Paid-In Capital(Or Share Stock) |
456,665,122.00 |
| Capital Surplus |
2,430,065,735.09 |
| Surplus Reserve |
31,196,425.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,166,283,428.44 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-253,375,407.82 |
| Owner's Equity（Stockholder's Equity） |
-253,375,407.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
274,803,153.51 |
